Trials / Unknown
UnknownNCT01846923
B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals
Study of the B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals With Beta-thalassemia Major
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Aghia Sophia Children's Hospital of Athens · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether one dose of the 13-valent pneumococcal conjugate vaccine (PCV13) induces immunological memory in asplenic adults and whether previously administered immunizations with the 23-valent polysaccharide pneumococcal vaccine influence the cellular immune response to PCV13 in this group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PCV13 |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-02-01
- First posted
- 2013-05-06
- Last updated
- 2013-05-06
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01846923. Inclusion in this directory is not an endorsement.